A detailed history of Vermillion Wealth Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Vermillion Wealth Management, Inc. holds 1,613 shares of ABT stock, worth $214,512. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,613
Previous 1,644 1.89%
Holding current value
$214,512
Previous $186 Million 15.09%
% of portfolio
0.06%
Previous 0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 28, 2025

SELL
$111.1 - $140.22 $3,444 - $4,346
-31 Reduced 1.89%
1,613 $214 Million
Q4 2024

Feb 21, 2025

BUY
$111.93 - $119.39 $184,012 - $196,277
1,644 New
1,644 $186 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $233B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Vermillion Wealth Management, Inc. Portfolio

Follow Vermillion Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vermillion Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vermillion Wealth Management, Inc. with notifications on news.